AUM CAPITAL (Your trust is our wealth)

facebook twitter linkedin
Careers

Market info

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1305.8570.85 (+5.74 %)
PREV CLOSE (Rs.) 1235.00
OPEN PRICE (Rs.) 1240.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 323979
TODAY'S LOW / HIGH (Rs.)1228.80 1308.60
52 WK LOW / HIGH (Rs.)1165.55 1672.2
NSE1305.9069.6 (+5.63 %)
PREV CLOSE( Rs. ) 1236.30
OPEN PRICE (Rs.) 1234.10
BID PRICE (QTY) 1305.90 (62)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5274028
TODAY'S LOW / HIGH(Rs.) 1227.60 1308.40
52 WK LOW / HIGH (Rs.)1165.7 1673
Home Market Info & ResearchCompany ProfileSmart Quotes
BSE NSE
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
4158.07
Dividend Yield(%)
1.23
TTM EPS (Rs.)
57.14
P/E Ratio
22.85
Book Value (Rs.)
419.19
Face Value (Rs.)
2
MCap (Rs. in Mn)
1054842.95
Price/Earning (TTM)
20.27
Price/Sales (TTM)
6.02
Price/Book (MRQ)
3.12
PAT Margin (%)
25.85
ROCE (%)
21.59
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Achin Gupta - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Website : www.cipla.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
23Apr Cipla’s arm gets USFDA’s final nod for
Cipla’s wholly owned subsidiary -- Cipla USA Inc (Cipla) has received fi..
23Apr Cipla informs about disclosure
Pursuant to the provisions of Regulation 30 read with Schedule III Part..
23Apr Cipla shines as its arm gets USFDA’s f
Cipla is currently trading at Rs. 1272.40, up by 37.40 points or 3.03% f..
more
QTR Dec 25 ANNUAL 25
Net Profit6168.8000000000151576.5
Gross Profit 7361.70000000001 64688.2
Operating Profit 11379 67631.6
Net Sales 44980.8 190448.5
more
Rs. in Millions
Onesource Specialty (BSE)
 1768.40 (9.78%)
M.Cap (Rs. in Cr)20273.41
Haleos Labs (BSE)
 1415.00 (9.39%)
M.Cap (Rs. in Cr)427.80
Dr. Reddy's Lab (BSE)
 1333.05 (9.54%)
M.Cap (Rs. in Cr)111263.95
Glenmark Pharma (BSE)
 2337.20 (4.27%)
M.Cap (Rs. in Cr)65955.97
PROMOTERS
29.21%
MUTUAL FUNDS/UTI
18.66%
NON-INSTITUTION
16.26%
FI/BANKS/INSURANCE
11.29%
GOVERNMENT
0%
FII
0%
more
CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances